Stephen Dilly, new Codexis president and CEO
July 19, 2022 09:10 AM EDT
People

Short­ly af­ter sell­ing Sier­ra to GSK, Stephen Dil­ly heads to en­zyme en­gi­neer Codex­is as new CEO

Kyle LaHucik

Senior Reporter

On Feb. 22, Stephen Dil­ly had no clear am­bi­tions of sell­ing Sier­ra On­col­o­gy to GSK. But that quick­ly changed over the sub­se­quent weeks, and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FTC to sue ma­jor PBMs over in­sulin re­bates, claim­ing they in­flat­ed pa­tient cost

Biotech VC firm out­lines plans for $100M fund

No­vo says its CB1 drug helped shed weight, but ef­fi­ca­cy and safe­ty ques­tions re­main

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

FDA OKs the first-ever self-ad­min­is­tered vac­cine, for flu

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times